Quintiles Transitional Holdings Inc. (NYSE:Q) was upgraded by equities researchers at Robert W. Baird from an “underperform” rating to a “neutral” rating in a report issued on Friday, Marketbeat.com reports. The firm currently has a $93.00 price objective on the medical research company’s stock, up from their prior price objective of $76.00. Robert W. Baird’s […]
